Close Menu
Home » Poised to Join Complex Market, Exosome Dx Publishes Validation Data for EGFR T790M Assay

Poised to Join Complex Market, Exosome Dx Publishes Validation Data for EGFR T790M Assay

Apr 02, 2018
|
Molika Ashford
Premium

NEW YORK (GenomeWeb) – Exosome Diagnostics has published a new study validating its exosome-based liquid biopsy assay for EGFR T790M testing in lung cancer patients, suggesting that its approach offers improved sensitivity over the only blood-based platform currently approved by the US Food and Drug Administration for this indication.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Increase Sought for 'Industries of the Future'

A bipartisan group of senators has introduced a bill seeking increased funding for certain fields, including synthetic biology, ScienceInsider reports. 

Coronavirus Case Reported in US

The Los Angeles Times reports that a case of the novel coronavirus making people ill in China has been reported in the US. 

Ring Materials

Discover magazine writes that paleoproteomics is increasing being used in archaeology, paleoanthropology, and paleontology, including a recent study of a 6,000-year-old ring. 

Nucleic Acids Research Papers Look at Light Mutagenesis, Synonymous Variants With Post-Transcriptional Effects, More

In Nucleic Acids Research this week: mutagenic effects of ultraviolet "A" light, post-transcription effects of synonymous mutations, and more.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

What's Popular?

In Molecular Diagnostics

  1. Quest Diagnostics Acquires Blueprint Genetics

  2. Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering

  3. Abbott Q4 Diagnostics Revenues up 5 Percent, MDx Revenues Decline

  4. Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent

  5. OraSure's DNA Genotek Gets FDA Clearance for Sample Collection Kits

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.